Literature DB >> 21490327

Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.

Stefan A J Timmer1, Paul Knaapen, Tjeerd Germans, Pieter A Dijkmans, Mark Lubberink, Jurrien M Ten Berg, Folkert J Ten Cate, Iris K Rüssel, Marco J W Götte, Adriaan A Lammertsma, Albert C van Rossum.   

Abstract

This study investigated the effects of alcohol septal ablation (ASA) on microcirculatory function and myocardial energetics in patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction. In 15 HCM patients who underwent ASA, echocardiography was performed before and 6 mo after the procedure to assess the LVOT gradient (LVOTG). Additionally, [(15)O]water PET was performed to obtain resting myocardial blood flow (MBF) and coronary vasodilator reserve (CVR). Changes in LV mass (LVM) and volumes were assessed by cardiovascular magnetic resonance imaging. Myocardial oxygen consumption (MVo(2)) was evaluated by [(11)C]acetate PET in a subset of seven patients to calculate myocardial external efficiency (MEE). After ASA, peak LVOTG decreased from 41 ± 32 to 23 ± 19 mmHg (P = 0.04), as well as LVM (215 ± 74 to 169 ± 63 g; P < 0.001). MBF remained unchanged (0.94 ± 0.23 to 0.98 ± 0.15 ml·min(-1)·g(-1); P = 0.45), whereas CVR increased (2.55 ± 1.23 to 3.05 ± 1.24; P = 0.05). Preoperatively, the endo-to-epicardial MBF ratio was lower during hyperemia compared with rest (0.80 ± 0.18 vs. 1.18 ± 0.15; P < 0.001). After ASA, the endo-to-epicardial hyperemic (h)MBF ratio increased to 1.03 ± 0.26 (P = 0.02). ΔCVR was correlated to ΔLVOTG (r = -0.82; P < 0.001) and ΔLVM (r = -0.54; P = 0.04). MEE increased from 15 ± 6 to 20 ± 9% (P = 0.04). Coronary microvascular dysfunction in obstructive HCM is at least in part reversible by relief of LVOT obstruction. After ASA, hMBF and CVR increased predominantly in the subendocardium. The improvement in CVR was closely correlated to the absolute reduction in peak LVOTG, suggesting a pronounced effect of LV loading conditions on microvascular function of the subendocardium. Furthermore, ASA has favorable effects on myocardial energetics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490327     DOI: 10.1152/ajpheart.00077.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

Review 1.  Coronary microvascular dysfunction: mechanisms and functional assessment.

Authors:  Paolo G Camici; Giulia d'Amati; Ornella Rimoldi
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

Review 2.  Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging.

Authors:  Attila Feher; Albert J Sinusas
Journal:  Circ Cardiovasc Imaging       Date:  2017-08       Impact factor: 7.792

3.  Medical, surgical and interventional management of hypertrophic cardiomyopathy with obstruction.

Authors:  Sammy Elmariah; Michael A Fifer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

4.  Characteristics of myocardial postsystolic shortening in patients with symptomatic hypertrophic obstructive cardiomyopathy before and half a year after alcohol septal ablation assessed by speckle tracking echocardiography.

Authors:  Jiansong Yuan; Shi Chen; Shubin Qiao; Fujian Duan; Jiafen Zhang; Hao Wang
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

5.  Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance.

Authors:  Claire E Raphael; Robert Cooper; Kim H Parker; Julian Collinson; Vassilis Vassiliou; Dudley J Pennell; Ranil de Silva; Li Yueh Hsu; Anders M Greve; Sukh Nijjer; Chris Broyd; Aamir Ali; Jennifer Keegan; Darrel P Francis; Justin E Davies; Alun D Hughes; Andrew Arai; Michael Frenneaux; Rod H Stables; Carlo Di Mario; Sanjay K Prasad
Journal:  J Am Coll Cardiol       Date:  2016-10-11       Impact factor: 24.094

6.  Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Rie Aoyama; Hitoshi Takano; Yasuhiro Kobayashi; Mitsunobu Kitamura; Kuniya Asai; Yasuo Amano; Shin-Ichiro Kumita; Wataru Shimizu
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

7.  Cardiac work is related to creatine kinase energy supply in human heart failure: a cardiovascular magnetic resonance spectroscopy study.

Authors:  Refaat E Gabr; AbdEl-Monem M El-Sharkawy; Michael Schär; Gurusher S Panjrath; Gary Gerstenblith; Robert G Weiss; Paul A Bottomley
Journal:  J Cardiovasc Magn Reson       Date:  2018-12-10       Impact factor: 5.364

8.  Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.

Authors:  Peter Magnusson; Jonny Nordström; Hendrik J Harms; Mark Lubberink; Fredrik Gadler; Jens Sörensen; Stellan Mörner
Journal:  Int J Cardiol Heart Vasc       Date:  2019-12-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.